Pharma Journalist -

Aro Biotherapeutics, a biotechnology company focused on developing a new generation of medicines based on its proprietary CENTYRIN technology, announced that Ionis Pharmaceuticals,…
Read More...

Scribe Therapeutics Inc., the company focused on engineering the most advanced platform for CRISPR-based genetic medicine, announced a research collaboration with Biogen Inc. to develop…
Read More...

ImmunoGen, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for IMGN632 for the treatment of patients with relapsed or…
Read More...

GlycoMimetics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the Company a Rare Pediatric Disease designation for rivipansel for the treatment of sickle…
Read More...

Eureka Therapeutics, Inc., a clinical stage biotechnology company developing novel T cell therapies to treat solid tumors, today announced the Company has initiated a Phase I/II…
Read More...

SpringWorks Therapeutics, Inc. announced that the company has entered into a clinical trial collaboration agreement with Pfizer Inc. (NYSE: PFE) to evaluate SpringWorks Therapeutics’…
Read More...

Nimble Therapeutics Inc. announced the company has entered into a strategic collaboration with Incyte to discover first-in-class peptide therapies across various disease areas. “This…
Read More...

Bristol Myers Squibb and MyoKardia, Inc. announced a definitive merger agreement under which Bristol Myers Squibb will acquire MyoKardia for $13.1 billion, or $225.00 per share in cash.…
Read More...

NVIDIA announced a partnership with global healthcare company GSK and its AI group, which is applying computation to the drug and vaccine discovery process. GSK has recently…
Read More...

World ADC is pleased to publish the winners of the 7th Annual World ADC Awards, held at World ADC Digital in September. The World ADC Awards reward the innovation, leadership, and…
Read More...